Astra pulls asthma product, hitting SkyePharma – Reuters

Astra pulls asthma product, hitting SkyePharma
Reuters
L) is ending production of the pressurised metered dose inhaler version of its asthma drug Pulmicort, due to technical problems, in a move that will hit its technology partner SkyePharma (SKP.L). SkyePharma developed the formulation for the medicine

and more »

View full post on asthma – Google News

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.